CX116 is an orally effective anti-inflammatory agent with significant anti-inflammatory properties. It exerts its effects by inhibiting inflammatory responses, reducing oxidative stress, protecting mitochondrial function, and preventing apoptosis (apoptosis). CX116 demonstrates acceptable toxicity and favorable pharmacokinetic characteristics, and it significantly safeguards mouse kidney tissue from Cisplatin-induced damage. CX116 is suitable for studying acute kidney injury caused by Cisplatin.
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
